Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$958M |
| 2 |
AbbVie
ABBV
|
+$955M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$762M |
| 4 |
CRH
CRH
|
+$705M |
| 5 |
Walmart Inc
WMT
|
+$700M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$604M |
| 2 |
DuPont de Nemours
DD
|
+$568M |
| 3 |
Applied Materials
AMAT
|
+$558M |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$277M |
| 5 |
Blackstone
BX
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.03% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Communication Services | 10.05% |
| 5 | Healthcare | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
American Shared Hospital Services
AMS
$10.1M
| $69K | ﹤0.01% |
32,665
| – | – |
|
4177
CXApp
CXAI
$17.7M
| $68.9K | ﹤0.01% |
207,427
+50,310
| +32% | +$28.9K |
|
4178
BioRestorative Therapies
BRTX
$5.61M
| $67.7K | ﹤0.01% |
57,854
+2,585
| +5% | +$3.44K |
|
|
TTRX
4179
Turn Therapeutics
TTRX
$312M
| $67.5K | ﹤0.01% |
+17,142
| New | +$71.5K |
|
4180
Edesa Biotech
EDSA
$52.2M
| $67.5K | ﹤0.01% |
46,537
+1,303
| +3% | +$2.55K |
|
4181
Astrotech Corp
ASTC
$18.3M
| $67.2K | ﹤0.01% |
18,780
| – | – |
|
|
NEUP
4182
Neuphoria Therapeutics
NEUP
$20.4M
| $67.1K | ﹤0.01% |
17,303
+4,325
| +33% | +$30.7K |
|
|
SNYR
4183
Synergy CHC Corp
SNYR
$2.35M
| $67K | ﹤0.01% |
36,038
+8,288
| +30% | +$17.8K |
|
4184
Mediaco Holding
MDIA
$78.3M
| $66.6K | ﹤0.01% |
114,759
-1,897
| -2% | -$1.85K |
|
4185
AEON Biopharma
AEON
$13.8M
| $66.1K | ﹤0.01% |
60,134
+13,061
| +28% | +$12.2K |
|
|
CNTB
4186
Connect Biopharma Holdings
CNTB
$144M
| $65.8K | ﹤0.01% |
23,320
| – | – |
|
4187
Metalpha Technology Holding
MATH
$42.3M
| $65.8K | ﹤0.01% |
31,314
| – | – |
|
4188
Envoy Medical
COCH
$57.9M
| $65K | ﹤0.01% |
98,351
+51,813
| +111% | +$41K |
|
|
NVNO
4189
enVVeno Medical
NVNO
$7.6M
| $64.6K | ﹤0.01% |
5,750
| – | – |
|
4190
VerifyMe
VRME
$9.58M
| $64.5K | ﹤0.01% |
107,352
-1,181
| -1% | -$1.02K |
|
4191
BioVie
BIVI
$23.2M
| $64.2K | ﹤0.01% |
55,381
+3,007
| +6% | +$4.84K |
|
4192
Bullfrog AI
BFRG
$11.1M
| $64.2K | ﹤0.01% |
72,715
+17,100
| +31% | +$20K |
|
4193
Alaunos Therapeutics
TCRT
$4.66M
| $63.8K | ﹤0.01% |
19,736
+3,945
| +25% | +$12.8K |
|
4194
Tenon Medical
TNON
$2.87M
| $63.4K | ﹤0.01% |
1,904
+490
| +35% | +$19.7K |
|
4195
Toro Corp
TORO
$195M
| $62.8K | ﹤0.01% |
11,890
| – | – |
|
|
NWTG
4196
Newton Golf Co
NWTG
$5.83M
| $62.3K | ﹤0.01% |
41,530
+13,001
| +46% | +$20.3K |
|
|
QNME
4197
Quanome Technologies, Inc. Common Stock
QNME
$17.6M
| $62.2K | ﹤0.01% |
69,900
+54,445
| +352% | +$57.2K |
|
4198
Amesite
AMST
$6.75M
| $61.4K | ﹤0.01% |
32,492
| – | – |
|
|
MYSE
4199
Myseum.AI Inc
MYSE
$12.6M
| $61.4K | ﹤0.01% |
36,333
-5,203
| -13% | -$12.4K |
|
|
BHST
4200
BioHarvest Sciences
BHST
$49.4M
| $61.3K | ﹤0.01% |
+11,811
| New | +$94.4K |
|
Similar funds
Geode Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Geode Capital Management held 4,586 positions worth $1.62T, up 3.4% from $1.57T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q4 2025 filing shows 113 new, 2,855 increased, 1,222 reduced and 117 closed positions. Its largest new stake was Qnity Electronics Inc: 5,358,208 shares worth $436M. The largest sale was Kellanova, an estimated $604M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q4 2025 buy was Qnity Electronics Inc: 5,358,208 shares worth $436M.
- Geode Capital Management added most to Microsoft in Q4 2025, an estimated $958M increase.
- Geode Capital Management's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $568M.
- Geode Capital Management fully exited Kellanova in Q4 2025, selling an estimated $604M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.62T portfolio in Q4 2025.
- Geode Capital Management opened 113 new positions and closed 117 in Q4 2025.
- Geode Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.62T.
Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.